SII Seeks DCGI Nod For Phase-3 Trial Of Covovax As Booster Dose
New Delhi: Pune-based vaccine manufacturer Serum Institute of India (SII) has sought permission from Drugs Controller General Of India (DCGI) ...
Tag: Serum Institute of India (SII)
